SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-011648
Filing Date
2022-08-02
Accepted
2022-08-02 16:17:18
Documents
103
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20220630x10q.htm   iXBRL 10-Q 2541492
2 EX-10.1 bpmc-20220630xex10d1.htm EX-10.1 341165
3 EX-10.2 bpmc-20220630xex10d2.htm EX-10.2 520393
4 EX-10.3 bpmc-20220630xex10d3.htm EX-10.3 1261583
5 EX-31.1 bpmc-20220630xex31d1.htm EX-31.1 11335
6 EX-31.2 bpmc-20220630xex31d2.htm EX-31.2 11406
7 EX-32.1 bpmc-20220630xex32d1.htm EX-32.1 10655
  Complete submission text file 0001558370-22-011648.txt   12182342

Data Files

Seq Description Document Type Size
8 EX-101.SCH bpmc-20220630.xsd EX-101.SCH 81577
9 EX-101.CAL bpmc-20220630_cal.xml EX-101.CAL 63244
10 EX-101.DEF bpmc-20220630_def.xml EX-101.DEF 297140
11 EX-101.LAB bpmc-20220630_lab.xml EX-101.LAB 566302
12 EX-101.PRE bpmc-20220630_pre.xml EX-101.PRE 504092
97 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20220630x10q_htm.xml XML 1720723
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 221128935
SIC: 2834 Pharmaceutical Preparations